BiomX Inc. (PHGE) › Cash & EquivalentsBiomX Inc. (PHGE) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2018-06-30: $4302018-12-31: $8.60M2019-06-30: $696.8K2019-12-31: $72.26M2020-12-31: $36.48M2021-12-31: $62.10M2022-12-31: $31.33M2023-12-31: $14.91M2024-12-31: $16.86M2025-12-31: $4.36M$4.36M2018-06-30Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$4.36M-74.1%2026-02-19Balance as of period end2024-12-31$16.86M+13.1%2026-02-19Balance as of period end2023-12-31$14.91M-52.4%2025-03-25Balance as of period end2022-12-31$31.33M-49.5%2024-04-04Balance as of period end2021-12-31$62.10M+70.2%2023-03-29Balance as of period end2020-12-31$36.48M-49.5%2022-03-30Balance as of period end2019-12-31$72.26M—2021-03-31Balance as of period end2019-06-30$696.8K—2019-08-21Balance as of period end2018-12-31$8.60M—2020-03-26Balance as of period end2018-06-30$430—2019-08-21Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)